Tumore alla vescica: interventi chirurgici eseguiti in un anno

Indice

• Descrizione indicatore
• Come si legge
• Fonte del dato
• Valutazione istituzionale
• Altre informazioni

Descrizione indicatore

L’indicatore ci consente di calcolare il numero di interventi chirurgici per tumori maligni della vescica eseguiti in un anno in una struttura ospedaliera.

Questo numero rappresenta il "volume" di interventi (indicatore di "volume").

Come si legge

L’indicatore si riferisce al grado di "competenza" e di "sicurezza" delle cure prestate.

Più alto è il numero di interventi chirurgici per tumori maligni della vescica eseguiti in una struttura ospedaliera, maggiore è il grado di esperienza della struttura stessa e la sicurezza del trattamento offerto.

Fonte del dato

Programma Nazionale Esiti 2024.
Confronto tra strutture calcolato su dati 2023.

Nota bene: per tener conto di errori nell’attribuzione di condizioni/interventi a singoli ospedali, sono state escluse dalle analisi tutte le strutture con volumi di attività molto bassi in relazione alla condizione considerata (volume di attività minimo 5 casi/anno).

Valutazione istituzionale

Il Gruppo di lavoro del Programma Nazionale Esiti ha stabilito che un ospedale dovrebbe eseguire almeno 20 interventi all’anno per tumore maligno alla vescica.
 
Il semaforo è calcolato sulla base del seguente documento ufficiale:

• Programma Nazionale Esiti. 2013. Amato L, Colais P, Davoli M, Ferroni E, Fusco D, Minozzi S, Moirano F, Sciattella P, Vecchi S, Ventura M, Perucci CA. Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data]. Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.

Consulta le strutture sanitarie che effettuano in un anno il maggior numero di interventi chirurgici per tumori alla vescica

Altre informazioni

Codici ICD-9-CM selezionati
Sono inclusi tutti i ricoveri, in regime ordinario, con diagnosi principale o secondaria di tumore maligno della vescica (ICD-9-CM 188, 198.1) ed intervento principale o secondario di cistectomia parziale o radicale (ICD-9-CM 57.6, 57.7).

Il volume di ricoveri per interventi chirurgici è calcolato su base annuale, riferito all’anno di dimissione del ricovero.

 
Fonti scientifiche

• Moschini M, Simone G, Stenzlc A, Gilld S, Cattoe J. Critical Review of Outcomes from Radical Cystectomy: Can Complications from Radical Cystectomy Be Reduced by Surgical Volume and Robotic Surgery? EU Focus 2016;2(1):19-29.
• Goossens-Laan CA, Gooiker GA, van Gijn W et al. A systematic review and meta-analysis of the relationship between hospital/surgeon volume and outcome for radical cystectomy: an update for the ongoing debate. Eur Urol 2011;59(5):775-83.
• Mayer EK, Purkayastha S, Athanasiou T, Darzi A, Vale JA. Assessing the quality of the volume-outcome relationship in uro-oncology. BJU Int 2009;103(3):341-9.
• Killeen SD, O'Sullivan MJ, Coffey JC, Kirwan WO, Redmond HP. Provider volume and outcomes for oncological procedures. Br J Surg 2005;92(4):389-402.
• Nuttall M, van der Meulen J, Phillips N et al. A systematic review and critique of the literature relating hospital or surgeon volume to health outcomes for 3 urological cancer procedures. J Urol 2004;172(6 Pt 1):2145-52.
• Azzouni FS, Din R, Rehman S et al. The first 100 consecutive, robot-assisted, intracorporeal ileal conduits: evolution of technique and 90-day outcomes. Eur Urol 2013;63(4):637-43.
• Barbieri CE, Lee B, Cookson MS et al. Association of procedure volume with radical cystectomy outcomes in a nationwide database. J Urol 2007;178(4 Pt 1):1418-21.
• Begg CB, Cramer LD, HoskinsWJ, Brennan MF. Impact of hospital volume on operative mortality for major cancer surgery. JAMA 1998;280(20):1747-51.
• Birkmeyer JD, Siewers AE, Finlayson EV et al. Hospital volume and surgical mortality in the United States. N Engl JMed 2002;346(15):1128-37.
• Birkmeyer JD, Stukel TA, Siewers AE, Goodney PP, Wennberg DE, Lucas FL. Surgeon volume and operative mortality in the United States. N Engl J Med 2003; 349(22):2117-27.
• Birkmeyer JD, Sun Y,Wong SL, Stukel TA. Hospital volume and late survival after cancer surgery. Ann Surg 2007;245(5):777-83.
• Elting LS, Pettaway C, Bekele BN et al. Correlation between annual volume of cystectomy, professional staffing, and outcomes: a statewide, population-based study. Cancer 2005;104(5):975-84.
• Fairey AS, Jacobsen NE, ChetnerMP et al. Associations between comorbidity, and overall survival and bladder cancer specific survival after radical cystectomy: results fromthe Alberta Urology Institute Radical Cystectomy database. J Urol 2009;182(1):85-92; discussion 93.
• Finlayson EV, Goodney PP, Birkmeyer JD. Hospital volume and operative mortality in cancer surgery: a national study. Arch Surg 2003;138(7):721-25; discussion 726.
• Gilbert SM, Dunn RL, Miller DC, Daignault S, Ye Z, Hollenbeck BK. Mortality after urologic cancer surgery: impact of non-index case volume. Urology 2008;71(5):906-10.
• GoodneyPP, StukelTA, LucasFL, FinlaysonEV, BirkmeyerJD. Hospitalvolume, length of stay, and readmission rates in high-risk surgery. Ann Surg 2003;238(2):161-67.
• Goossens-Laan CA, Visser O, Wouters MW et al. Variations in treatment policies and outcome for bladder cancer in the Netherlands. Eur J Surg Oncol 2010;36 Suppl 1:S100-07.
• Gore JL, Yu HY, Setodji C, Hanley JM, Litwin MS, Saigal CS; Urologic diseases in America Project. Urinary diversion and morbidity after radical cystectomy for bladder cancer. Cancer 2010;116(2):331-39.
• Hayn MH, Hellenthal NJ, Hussain A et al. Does previous robot-assisted radical prostatectomy experience affect outcomes at robot-assisted radical cystectomy? Results from the International Robotic Cystectomy Consortium. Urology 2010;76(5):1111-16.
• Hayn MH, Hellenthal NJ, Seixas-Mikelus SA et al. Is patient outcome compromised during the initial experience with robot-assisted radical cystectomy? Results of 164 consecutive cases. BJU Int 2011;108(6):882-87.
• Hollenbeck BK, Daignault S, Dunn RL, Gilbert S, Weizer AZ, Miller DC. Getting under the hood of the volume-outcome relationship for radical cystectomy. J Urol 2007;177(6):2095-99.
• Hollenbeck BK,Wei Y, Birkmeyer JD. Volume, process of care, and operative mortality for cystectomy for bladder cancer. Urology 2007;69(5):871-75.
• Kim SP, Boorjian SA, Shah ND et al. Contemporary trends of in-hospital complications and mortality for radical cystectomy. BJU Int 2012;110(8):1163-68.
• Konety BR, Allareddy V, Herr H. Complications after radical cystectomy: analysis of population-based data. Urology 2006;68(1):58-64.
• Konety BR, Dhawan V, Allareddy V, Joslyn SA. Impact of hospital and surgeon volume on in-hospital mortality from radical cystectomy: data from the health care utilization project. J Urol 2005;173(5):1695-700.
• Leow JJ, Reese S, Trinh QD et al. Impact of surgeon volume on the morbidity and costs of radical cystectomy in the USA: a contemporary population-based analysis. BJU Int 2015;115(5):713-21.
• Mayer EK, Bottle A, Aylin P, Darzi AW, Athanasiou T, Vale JA. Them volume-outcome relationship for radical cystectomy in England: an analysis of outcomes other than mortality. BJU Int 2011;108(8 Pt 2):E258-65.
• Mayer EK, Bottle A, Darzi AW, Athanasiou T, Vale JA. The volume-mortality relation for radical cystectomy in England: retrospective analysis of hospital episode statistics. BMJ 2010;340:c1128.
• McCabe JE, Jibawi A, Javle P. Defining the minimum hospital case-load to achieve optimum outcomes in radical cystectomy. BJU Int 2005;96(6):806-10.
• Santos F, Zakaria AS, Kassouf W, Tanguay S, Aprikian A. High hospital and surgeon volume and its impact on overall survival after radical cystectomy among patients with bladder cancer in Quebec. World J Urol 2015;33(9):1323-30.
• Sun M, Ravi P, Karakiewicz PI et al. Is there a relationship between leapfrog volume thresholds and perioperative outcomes after radical cystectomy? Urol Oncol 2014;32(1):27.e7-13.